<DOC>
	<DOC>NCT02036671</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and efficacy of the FLEX System when used to create an arteriovenous fistula (AVF or AV fistula) percutaneously in patients with Chronic Kidney Disease (CKD) who require hemodialysis vascular access.</brief_summary>
	<brief_title>Novel Endovascular Access Trial (NEAT)</brief_title>
	<detailed_description>This is a 12 month multi-center non-randomized investigational study to evaluate the safety and efficacy of the FLEX system to create an endovascular AVF in patients with CKD who require hemodialysis vascular access.</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria>Eligible for a native surgical arteriovenous fistula, as determined by the treating physician. Adult (age &gt;18 years old). Established, nonreversible kidney failure requiring hemodialysis. Written informed consent obtained. Functioning surgical access in the planned treatment arm. Pregnant women. New York Heart Association (NYHA) class III or IV heart failure. Allergy to contrast dye.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Arteriovenous fistula</keyword>
	<keyword>Fistula</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>Percutaneous</keyword>
	<keyword>Kidney Disease</keyword>
	<keyword>Kidney Failure, Chronic</keyword>
	<keyword>Urologic Diseases</keyword>
	<keyword>Renal Insufficiency, Chronic</keyword>
	<keyword>Renal Insufficiency</keyword>
	<keyword>CKD</keyword>
	<keyword>hemodialysis</keyword>
</DOC>